PHILOGEN SPA (PHIL.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:PHIL • IT0005373789
21.15 EUR
+0.05 (+0.24%)
Last: Jan 30, 2026, 05:26 PM
PHIL gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 85 industry peers in the Biotechnology industry. PHIL is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. PHIL is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, PHIL could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
- PHIL had positive earnings in the past year.
- PHIL had a positive operating cash flow in the past year.
- In the past 5 years PHIL reported 4 times negative net income.
- PHIL had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- PHIL has a Return On Assets of 28.81%. This is amongst the best in the industry. PHIL outperforms 96.47% of its industry peers.
- Looking at the Return On Equity, with a value of 36.49%, PHIL belongs to the top of the industry, outperforming 95.29% of the companies in the same industry.
- The Return On Invested Capital of PHIL (21.08%) is better than 98.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.81% | ||
| ROE | 36.49% | ||
| ROIC | 21.08% |
ROA(3y)5.82%
ROA(5y)-1.99%
ROE(3y)6.79%
ROE(5y)-3.69%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- PHIL's Profit Margin of 58.33% is amongst the best of the industry. PHIL outperforms 96.47% of its industry peers.
- PHIL's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 49.47%, PHIL belongs to the best of the industry, outperforming 97.65% of the companies in the same industry.
- PHIL has a better Gross Margin (74.04%) than 61.18% of its industry peers.
- PHIL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 49.47% | ||
| PM (TTM) | 58.33% | ||
| GM | 74.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y40.66%
GM growth 3YN/A
GM growth 5Y18.26%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHIL is creating value.
- The number of shares outstanding for PHIL remains at a similar level compared to 1 year ago.
- The number of shares outstanding for PHIL has been reduced compared to 5 years ago.
- The debt/assets ratio for PHIL has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 13.39 indicates that PHIL is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 13.39, PHIL belongs to the top of the industry, outperforming 90.59% of the companies in the same industry.
- The Debt to FCF ratio of PHIL is 0.31, which is an excellent value as it means it would take PHIL, only 0.31 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 0.31, PHIL belongs to the top of the industry, outperforming 89.41% of the companies in the same industry.
- A Debt/Equity ratio of 0.08 indicates that PHIL is not too dependend on debt financing.
- The Debt to Equity ratio of PHIL (0.08) is better than 65.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.31 | ||
| Altman-Z | 13.39 |
ROIC/WACC2.6
WACC8.1%
2.3 Liquidity
- A Current Ratio of 5.73 indicates that PHIL has no problem at all paying its short term obligations.
- PHIL has a better Current ratio (5.73) than 84.71% of its industry peers.
- A Quick Ratio of 5.52 indicates that PHIL has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 5.52, PHIL belongs to the top of the industry, outperforming 85.88% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.73 | ||
| Quick Ratio | 5.52 |
3. Growth
3.1 Past
- PHIL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 255.77%, which is quite impressive.
- PHIL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 100.72% yearly.
- Looking at the last year, PHIL shows a very strong growth in Revenue. The Revenue has grown by 3346.54%.
- The Revenue has been growing by 42.46% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)255.77%
EPS 3YN/A
EPS 5Y100.72%
EPS Q2Q%3.48%
Revenue 1Y (TTM)3346.54%
Revenue growth 3Y209.5%
Revenue growth 5Y42.46%
Sales Q2Q%606.29%
3.2 Future
- Based on estimates for the next years, PHIL will show a decrease in Earnings Per Share. The EPS will decrease by -3.40% on average per year.
- PHIL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.55% yearly.
EPS Next Y14.73%
EPS Next 2Y-53.92%
EPS Next 3Y-63.96%
EPS Next 5Y-3.4%
Revenue Next Year112.03%
Revenue Next 2Y-23.41%
Revenue Next 3Y-35.23%
Revenue Next 5Y22.55%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 18.55, the valuation of PHIL can be described as rather expensive.
- 87.06% of the companies in the same industry are more expensive than PHIL, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 28.32. PHIL is valued slightly cheaper when compared to this.
- The Price/Forward Earnings ratio is 16.93, which indicates a correct valuation of PHIL.
- 85.88% of the companies in the same industry are more expensive than PHIL, based on the Price/Forward Earnings ratio.
- PHIL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.55 | ||
| Fwd PE | 16.93 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PHIL is valued cheaper than 89.41% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIL indicates a rather cheap valuation: PHIL is cheaper than 91.76% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.8 | ||
| EV/EBITDA | 10.26 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- PHIL has a very decent profitability rating, which may justify a higher PE ratio.
- A cheap valuation may be justified as PHIL's earnings are expected to decrease with -63.96% in the coming years.
PEG (NY)1.26
PEG (5Y)0.18
EPS Next 2Y-53.92%
EPS Next 3Y-63.96%
5. Dividend
5.1 Amount
- No dividends for PHIL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
PHILOGEN SPA / PHIL.MI FAQ
What is the fundamental rating for PHIL stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHIL.MI.
What is the valuation status for PHIL stock?
ChartMill assigns a valuation rating of 6 / 10 to PHILOGEN SPA (PHIL.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for PHILOGEN SPA?
PHILOGEN SPA (PHIL.MI) has a profitability rating of 6 / 10.
What is the expected EPS growth for PHILOGEN SPA (PHIL.MI) stock?
The Earnings per Share (EPS) of PHILOGEN SPA (PHIL.MI) is expected to grow by 14.73% in the next year.